This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pasteur Limited. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: William Lapps - Innovator in Reverse Transcriptase Detection
Introduction
William Lapps is a notable inventor based in Nazareth, PA (US). He has made significant contributions to the field of molecular biology, particularly in the detection of reverse transcriptase activity. His work is crucial for ensuring the safety of biological products, including viral vaccines.
Latest Patents
Lapps holds a patent for the invention titled "CoRT-PCR assay for the discrimination of endogenous reverse transcriptase activity in eukaryotic cell lines from infectious retrovirus contamination." This invention relates to a method for detecting reverse transcriptase enzymatic activity in eukaryotic cell lines. The method allows for the discrimination between endogenous reverse transcriptase activity and exogenous infectious retrovirus, which is vital for the production of safe biological products.
Career Highlights
William Lapps is associated with Aventis Pasteur Limited, where he has applied his expertise in molecular biology. His innovative approach has led to advancements in the safety protocols for viral vaccine production. Lapps' work is recognized for its impact on the field and its potential to improve public health outcomes.
Collaborations
Lapps has collaborated with notable colleagues, including Scott J Goebel and Maurice Harmon. These partnerships have contributed to the development and refinement of his patented technologies.
Conclusion
William Lapps is a distinguished inventor whose work in reverse transcriptase detection has significant implications for the safety of biological products. His contributions continue to influence the field of molecular biology and vaccine development.